PREDNISONE TABLETS
Leukemia Cutis
National Cancer Institute (NCI)Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Leukemia Cutis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 National Cancer Institute (NCI) | Phase 3 | BB |
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT) National Cancer Institute (NCI) | Phase 3 | BB |
ETOPOSIDE National Cancer Institute (NCI) | Phase 3 | BB |
Daunorubicin National Cancer Institute (NCI) | Phase 3 | BB |
Cytosin-Arabinosid National Cancer Institute (NCI) | Phase 3 | BB |
View all 15 →
Same molecule, other indications
PREDNISONE TABLETS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →